Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients (Q34587999)

3 August 2017

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

Gideon J. Mellenbergh

4

object named as

Gideon J Mellenbergh

1 reference

3 August 2017

Sanne B Schagen

1

1 reference

3 August 2017

Martin J Muller

2

1 reference

3 August 2017

Willem Boogerd

3

1 reference

3 August 2017

Frits S A M van Dam

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Journal of the National Cancer Institute

3 August 2017

1 reference

3 August 2017

98

1 reference

3 August 2017

23

1 reference

3 August 2017

1742-1745

1 reference

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

3 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Principles of defining reliable change indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ470

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ470

1 reference

3 August 2017

1 reference